Pseudomyxoma peritonei epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) |
Nima Nasiri (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
*The overall incidence of pseudomyxoma peritonei is 0.1 cases per 100,000 people per year. <ref name="pmid18043976">{{cite journal |vauthors=Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M |title=Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) |journal=Ann. Surg. Oncol. |volume=15 |issue=2 |pages=526–34 |date=February 2008 |pmid=18043976 |doi=10.1245/s10434-007-9691-2 |url=}}</ref> | *The overall incidence of pseudomyxoma peritonei is 0.1 cases per 100,000 people per year. <ref name="pmid17524597">{{cite journal |vauthors=Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA |title=Appendiceal neoplasms and pseudomyxoma peritonei: a population based study |journal=Eur J Surg Oncol |volume=34 |issue=2 |pages=196–201 |date=February 2008 |pmid=17524597 |doi=10.1016/j.ejso.2007.04.002 |url=}}</ref><ref name="pmid18043976">{{cite journal |vauthors=Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M |title=Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) |journal=Ann. Surg. Oncol. |volume=15 |issue=2 |pages=526–34 |date=February 2008 |pmid=18043976 |doi=10.1245/s10434-007-9691-2 |url=}}</ref> | ||
*Pseudomyxoma peritonei is slightly more common in females than males | *Pseudomyxoma peritonei is slightly more common in females than males | ||
* The female to male ratio is 11:9. | * The female to male ratio is 11:9. | ||
Revision as of 20:04, 11 January 2019
|
Pseudomyxoma peritonei Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pseudomyxoma peritonei epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pseudomyxoma peritonei epidemiology and demographics |
|
Pseudomyxoma peritonei epidemiology and demographics in the news |
|
Blogs on Pseudomyxoma peritonei epidemiology and demographics |
|
Risk calculators and risk factors for Pseudomyxoma peritonei epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Epidemiology and Demographics
- The overall incidence of pseudomyxoma peritonei is 0.1 cases per 100,000 people per year. [1][2]
- Pseudomyxoma peritonei is slightly more common in females than males
- The female to male ratio is 11:9.
- The median age at presentation is typically about 50 years of age.
References
- ↑ Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA (February 2008). "Appendiceal neoplasms and pseudomyxoma peritonei: a population based study". Eur J Surg Oncol. 34 (2): 196–201. doi:10.1016/j.ejso.2007.04.002. PMID 17524597.
- ↑ Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M (February 2008). "Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)". Ann. Surg. Oncol. 15 (2): 526–34. doi:10.1245/s10434-007-9691-2. PMID 18043976.